APA

Resnick I. B., Aker M., Tsirigotis P., Shapira M. Y., Abdul-Hai A., Bitan M., Gesundheit B., Amar A., Ackerstein A., Samuel S., Slavin S. & Or R. (20071213). Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. : Bone marrow transplantation.

Chicago

Resnick I B, Aker M, Tsirigotis P, Shapira M Y, Abdul-Hai A, Bitan M, Gesundheit B, Amar A, Ackerstein A, Samuel S, Slavin S and Or R. 20071213. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. : Bone marrow transplantation.

Harvard

Resnick I. B., Aker M., Tsirigotis P., Shapira M. Y., Abdul-Hai A., Bitan M., Gesundheit B., Amar A., Ackerstein A., Samuel S., Slavin S. and Or R. (20071213). Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. : Bone marrow transplantation.

MLA

Resnick I B, Aker M, Tsirigotis P, Shapira M Y, Abdul-Hai A, Bitan M, Gesundheit B, Amar A, Ackerstein A, Samuel S, Slavin S and Or R. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. : Bone marrow transplantation. 20071213.